Rare Meets Real

Our Worldwide Evidence team is dedicated to the development and implementation of health economics and outcomes research, observational studies and patient registries, and patient communities in key orphan diseases.

Often combining prospective research with innovative data sources, we balance the needs of clinical development with marketplace realities demanding the generation and communication of real-world evidence with clinical, economic, and humanistic value.

At Worldwide, we combine our focused experience in rare diseases with our Worldwide Evidence expertise to design solutions for both regulatory approval and commercial success.

For early-stage clients in particular, we develop strategic evidence plans to guide the inclusion of measures critical to marketplace success, while serving as an important business asset to optimize enterprise value.

To learn more about Worldwide Clinical Trials, visit their Clinical Leader page.